1779TiP Phase II clinical study evaluating the efficacy and safety of disitamab vedotin in patients (pts) with HER2-expressing urothelial carcinoma (RC48G001)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; p. S1351
Main Authors Koshkin, V.S., Powles, T.B., Iyer, G., Loriot, Y., Drakaki, A., Duran Martinez, I., De Santis, M., Retz, M., Jain, R.K., Chan, S., Ichimaru, M., Galsky, M.D.
Format Journal Article
LanguageEnglish
Published 01.09.2022
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.1938